Concepedia

Satheeshmanikandan Thappali

ST

Statistics

Publications

6

Citations

162

H-Index

6

Active since

2012

Affiliations

Horizon Therapeutics (United Kingdom)(Current)

PRIST University

Satheeshmanikandan Thappali is an author at Horizon Therapeutics (United Kingdom) specializing in drug analysis, medicine, and pharmacology.

Top concepts

Publications per year

2012–2014

6

Publications

6

Simultaneous quantification of lenalidomide, ibrutinib and its active metabolite PCI-45227 in rat plasma by LC–MS/MS: Application to a pharmacokinetic study

Sridhar Veeraraghavan, Srikant Viswanadha, Satheeshmanikandan Thappali et al. · Journal of Pharmaceutical and Biomedical Analysis · 2014 · 59 citations

, , +8

Simultaneous quantification of ruxolitinib and nilotinib in rat plasma by LC–MS/MS: Application to a pharmacokinetic study

Sridhar Veeraraghavan, Satheeshmanikandan Thappali, Srikant Viswanadha et al. · Journal of Pharmaceutical and Biomedical Analysis · 2014 · 28 citations

, , +9

Simultaneous quantification of idelalisib, fludarabine and lenalidomide in rat plasma by using high-performance liquid chromatography coupled with heated electrospray ionization tandem mass spectrometry

Sridhar Veeraraghavan, Satheeshmanikandan Thappali, Srikant Viswanadha et al. · Journal of Chromatography B · 2014 · 21 citations

, , +11

Simultaneous Determination of Celecoxib, Erlotinib, and its Metabolite Desmethyl-Erlotinib (OSI-420) in Rat Plasma by Liquid Chromatography/Tandem Mass Spectrometry with Positive/Negative Ion-Switching Electrospray Ionisation

Satheeshmanikandan Thappali · Scientia Pharmaceutica · 2012 · 21 citations · Full text

Simultaneous Determination of Methotrexate, Dasatinib and its Active Metabolite N- Deshydroxyethyl Dasatinib in Rat Plasma by LC-MS/MS: Method Validation and Application to Pharmacokinetic Study

Satheeshmanikandan Thappali, Kanthikiran V. S. Varanasi, Sridhar Veeraraghavan et al. · Arzneimittelforschung · 2012 · 17 citations

, , +18

Rows per page

1–5 of 6